Post-approval studies (Phase 4)WithdrawnNCT00858754
What this trial is testing
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc.